Subha Krishnan

Subha Krishnan has been working in the field of science since 2010. Subha started as a Staff Scientist and PostDoc at TGEN, then moved to Ashion Analytics as a Clinical Curation Scientist in 2015. In 2016, they became a Research Scientist at Human Longevity, Inc. and in 2017, they were Lead Translational Scientist and Senior Translational Scientist at Viome. Currently, Subha Krishnan is the Director at CureMatch, Inc.

Subha Krishnan received their Doctor of Philosophy (Ph.D.) in Biochemistry and Molecular Biology from Indiana University–Purdue University Indianapolis in 2011. Subha also earned their Master of Science (M.S.) in Bioinformatics from the same university in 2004. Prior to that, they obtained their M.S. in Genetics from India.